Page 93 - Faculty of Health Sciences

Basic HTML Version

FACULTY OF health scienceS
Mannino, D.M. and Buist, S.A. 2011. Results From the
Population-Based Burden of Obstructive Lung Disease
Study. Chest, 139(4): 752-763.
Langat, M.K., Crouch, N., Smith, P.J. and Mulholland,
D.A. 2011. Cembranolides from the Leaves of Croton
gratissimus. Journal of Natural Products, 74: 2349-2355.
Lawn, S.D. and Meintjes, G. 2011. Pathogenesis and
prevention of immune reconsitution disease during
antiretroviral therapy. Expert Review of Anti-Infective
Therapy, 9(4): 415-430.
Lawn, S.D. and Nicol, M.P. 2011. Xpert (R) MTB/RIF
assay: development, evaluation and implementation of
a new rapid molecular diagnostic for tuberculosis and
rifampicin resistance. Future Microbiology, 6(9): 1067-
Lawn, S.D. and Wood, R. 2011. Poor Prognosis of
HIV-Associated Tuberculosis Meningitis Regardless of
the Timing of Antiretroviral Therapy. Clinical Infectious
Diseases, 52(11): 1384-1387.
Lawn, S.D. and Wood, R. 2011. Tuberculosis in
Antiretroviral Treatment Services in Resource-Limited
Setting: Addressing the Challenges of Screening and
Diagnosis. Journal of Infectious Diseases, 204: 1159-1167.
Lawn, S.D. and Zumla, A. 2011. Tuberculosis. Lancet, 378:
Lawn, S.D., Ayles, H., Egwaga, S., Williams, B., Mukadi,
Y.D., Santos-Filho, E.D., Godfrey-Faussett, P., Granich,
R. and Harries, A.D. 2011. Potential utility of emperical
tuberculosis treatment for HIV-infected patients with
advanced immunodeficiency in high TB-HIV burden
settings. International Journal of Tuberculosis and Lung
Disease, 15(3): 287-295.
Lawn, S.D., Brooks, S.V., Kranzer, K., Nicol, M.P., Whitelaw,
A.C., Vogt, M.C., Bekker, L. and Wood, R. 2011. Screening
of HIV-associated tuberculosis and rifampicin resistance
before antiretroviral therapy using the Xpert MTB/RIF
assay: A prospective study. Plos Medicine, 8(7): e1001067.
Lawn, S.D., Campbell, L., Kaplan, R., Boulle, A.M., Cornell,
M., Kerschberger, B., Morrow, C.D., Little, F., Egger, M.
and Wood, R. 2011. Time to initiation of Antiretroviral
Therapy Among Patients with HIV-Associated Tuberculosis
in Cape Town, South Africa. Jaids-Journal of Acquired
Immune Deficiency Syndromes, 57(2): 136-140.
Lawn, S.D., Campbell, L., Kaplan, R., Little, F., Morrow,
C.D. and Wood, R. 2011. Delays in starting antiretroviral
therapy in patients with HIV-associated tuberculosis
accessing non-integrated clinical services in a South
African township. BMC Infectious Diseases, 11:258. (9pp)
Lawn, S.D., Fraenzel, A., Kranzer, K., Caldwell, J.,
Bekker, L. and Wood, R. 2011. Provider-initiated HIV
testing increases access of patients with HIV-associated
tuberculosis to antiretroviral treatment. SAMJ South African
Medical Journal, 101(4): 258-262.
Lawn, S.D., Harries, A.D., Williams, B., Chaisson, R.,
Losina, E., De Cock, K.M. and Wood, R. 2011. Antiretroviral
therapy and the control of HIV-associated tuberculosis.
Will ART do it? International Journal of Tuberculosis and
Lung Disease, 15(5): 571-581.
Lawn, S.D., Torok, M.E. and Wood, R. 2011. Optimum
time to start antiretroviral therapy during HIV-associated
opportunistic infections. Current Opinion in Infectious
Diseases, 24: 34-42.
Lawn, S.D., Wood, R. and Wilkinson, R.J. 2011. Changing
Concepts of “Latent Tuberculosis Infection” in Patients
Living with HIV Infection. Clinical & Developmental
Immunology, 2011: 980594. (9pp).
Lecour, S. and James, R.W. 2011. When are pro-
inflammatory cytokines SAFE in heart failure? European
Heart Journal, 32: 680-685.
Lecour, S. and Lamont, K. 2011. Natural polyphenols and
cardioprotection. Mini-Reviews in Medicinal Chemistry,
11(14): 1191-1199.
Lehloenya, R., Todd, G., Badri, M. and Dheda, K.
2011. Outcomes of reintroducing anti-tuberculosis drug
following cutaneous adverse drug reactions. International
Journal of Tuberculosis and Lung Disease, 15(12): 1649-
Lemmer, C.E., Badri, M., Visser, M.E. and Mayosi, B.M.
2011. A lower body mass index is associated with
cardiomyopathy in people with HIV infection: Evidence
from a case comparison study. SAMJ South African
Medical Journal, 101(2): 119-121.
Levison, J.H., Orrell, C., Losina, E., Lu, Z., Freedberg,
K.A. and Wood, R. 2011. Early outcomes and the
virologic impact delayed treatment switching on second-
line therapy in an antiretroviral roll-out program in South
Africa. Antiviral Therapy, 16(6): 853-861.
Levitt, N., Steyn, K., Dave, J.A. and Bradshaw, D.
2011. Chronic noncommunicable disease and HIV-
AIDS on a collision course: relevance for health care
delivery, particulary in low-resource settings-insights
from South Africa. American Journal of Clinical Nutrition,
94: 1690S-1696S.
Ling, D., Pai, M., Davids, V., Brunet, L., Lenders, L.,
Meldau, R., Calligaro, G., Allwood, B., Van Zyl Smit, R.,
Peter, J., Bateman, E.D., Dawson, R. and Dheda, K. 2011.